Literature DB >> 9892338

Significant weight gain with rezulin therapy.

D M Gorson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9892338     DOI： 10.1001/archinte.159.1.99

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Control of lower extremity edema in patients with diabetes: Double blind randomized controlled trial assessing the efficacy of mild compression diabetic socks.

Authors:  Stephanie C Wu; Ryan T Crews; Melissa Skratsky; Julia Overstreet; Sai V Yalla; Michelle Winder; Jacquelyn Ortiz; Charles A Andersen
Journal:  Diabetes Res Clin Pract       Date:  2017-02-27       Impact factor: 5.602

2.  Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability.

Authors:  I Idris; S Gray; R Donnelly
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

Review 3.  Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents.

Authors:  Ligia J Dominguez; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

4.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

5.  Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.

Authors:  Ferruh Artunc; Diana Sandulache; Omaima Nasir; Krishna M Boini; Björn Friedrich; Norbert Beier; Edith Dicks; Sven Pötzsch; Karin Klingel; Kerstin Amann; Bonnie L Blazer-Yost; Wolfgang Scholz; Teut Risler; Dietmar Kuhl; Florian Lang
Journal:  Pflugers Arch       Date:  2008-01-03       Impact factor: 3.657

Review 6.  Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.